Mayet Mayet
Product Blog Resources About
Contact Us
  1. Blog
  2. General
  3. Page 7
  • Best Practices for Maintaining Regulatory Compliance in Vendor Management and Oversight

    Jul 26, 2023

    —

    by

    Tom Lazenby
    in General
    Best Practices for Maintaining Regulatory Compliance in Vendor Management and Oversight

    Clinical Trials are complex and even more so when multiple key deliverables are outsourced by Sponsors. It is critical for Sponsors to ensure regulatory compliance and patient safety and data integrity. The cost of non-compliance can be significant and anxiety-inducing to the most diligent clinical research professionals. Regulatory inspection findings can lead to increased scrutiny,…

    Read more »: Best Practices for Maintaining Regulatory Compliance in Vendor Management and Oversight
  • Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk Management

    Jul 19, 2023

    —

    by

    Tom Lazenby
    in General
    Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk Management

    The FDA guidance on quality risk management released in May (2023) offers principles and examples applicable to various pharmaceutical quality aspects. The principles of quality risk management in this guidance can be extended to clinical trial vendor risk management, covering different stages of a clinical trial. When applied to clinical trial vendor risk management, the…

    Read more »: Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk Management
  • Vendor Level vs Study Level Vendor Risk Assessment: A Robust Approach

    Jul 12, 2023

    —

    by

    Tom Lazenby
    in General
    Vendor Level vs Study Level Vendor Risk Assessment: A Robust Approach

    Clinical trial vendor management requires a strategic approach, proactive thinking, and a deep understanding of vendor risk assessment at both the vendor and study levels. Two approaches to vendor risk assessment — vendor level and study level — serve to manage different types of risk. The assessments are complementary and critical to clinical trial delivery.…

    Read more »: Vendor Level vs Study Level Vendor Risk Assessment: A Robust Approach
  • Welcome to Mayet: Spearheading change in Clinical Research Vendor Management

    Jul 10, 2023

    —

    by

    Tom Lazenby
    in General
    Welcome to Mayet: Spearheading change in Clinical Research Vendor Management

    We are excited to introduce Mayet, an innovative all-in-one solution in the world of clinical research outsourcing. Clinical research is a vital process that opens new avenues for treatment. However, it is fraught with complexities and challenges, particularly in the realm of vendor management. Fragmented systems, inefficient processes, lack of visibility, and increased risk are…

    Read more »: Welcome to Mayet: Spearheading change in Clinical Research Vendor Management
←Previous Page

Search

Topics

  • General

Latest Posts

  • From Spreadsheet Prison to Second Brain: The Upgrade That Pays for Itself
  • The Quiet Exhaustion of Clinical Project Managers
  • Digital Oversight Is Here: Manual Systems Are the New Compliance Risk
  • Why Validation Documentation Alone Isn’t Enough (And What Actually Is)
  • 99 Problems in Vendor Management
  • Mayet Goes Modular!
  • Integration Partnership with PHARMASEAL CTMS

Footer

Mayet

Mayet Solutions Ltd
London, W1W 5PF
United Kingdom

Phone: +44 792 012 2927

LinkedIn

Mayet Software

  • Product
  • Request Demo

Resources

  • Briefing
  • Webinar
  • GCP R3 Seminar
  • White Paper
  • Resources

Company

  • Blog
  • Contact
  • About
  • Security & Compliance
  • Legal

© 2023-2024 Mayet Solutions Ltd – All rights reserved

Cyber Essentials Plus Certified